City of Hope Gives von Gunten Humanitarian Award

 

January 28, 2008  |  

Charles von Gunten, M.D., Ph.D., Associate Clinical Professor of Medicine at UCSD, is the 2007 recipient of the Sarnat Distinguished Humanitarian Award, given by the City of Hope Comprehensive Cancer Center in recognition of outstanding scientific and humanitarian achievement in hospice and palliative care. 

Charles von Gunten, M.D., Ph. D.

Charles von Gunten, M.D., Ph. D.

Von Gunten is a member of the Moores UCSD Cancer Center, and medical director of the Doris A. Howell Service, a clinical consultation service for palliative and supportive care, which is based at the Cancer Center. He holds an established investigator award from the National Cancer Institute and is editor-in-chief of the Journal of Palliative Medicine. He also holds the position of Provost of the Center for Palliative Studies at San Diego Hospice & Palliative Care, which sponsors the largest fellowship program in palliative medicine in the U.S.  

This is the 12th year the Sarnat award has been given by the City of Hope Comprehensive Cancer Center in Duarte, California.

###

Media Contact: Nancy Stringer, 619-543-6163, nstringer@ucsd.edu


Related Specialties

UCSD Moores Cancer Center


Media Contact

Share This Article


Related News

9/10/2019
UC San Diego researchers say that measuring how quickly a person’s pupil dilates while they are taking cognitive tests may be a low-cost, low-invasive method to aid in screening individuals at increas ...
9/5/2019
The San Diego Center for AIDS Research (CFAR) at University of California San Diego has been awarded planning grants to help the federal government achieve its goal of reducing the number of new HIV i ...
9/3/2019
A new University of California San Diego School of Medicine study links changes in the gene for the protein focal adhesion kinase, or FAK, to ovarian cancer’s ability to survive chemotherapy.
9/3/2019
CARB-X, an international funder of efforts to fight antimicrobial resistance, is awarding up to $15 million to develop a strep throat vaccine based on original research at UC San Diego.



Follow Us